Assessing Adherence to Digital Health Technologies Among Hispanic/Latino Adults With or At Risk of Type 2 Diabetes:
Completed
Conditions studied: Diabetes Mellitus, Type 2, Depression, Anxiety, Diet Habit
In brief
In an effort to personalize medical care, novel approaches have been used to categorize sub-populations of patients with type 2 diabetes (T2D). These are based on biological and genetic variables, allowing identification of clusters with significantly different clinical characteristics and risks of complications that may be more amenable to targeted and precise therapeutic interventions. Increasingly, wearable and other digital health technologies have the potential to capture additional and objective information to support personalized medicine but at present underserved populations have largely been excluded from clinical trials incorporating digital health. With this study, the Investigators aim to build on prior work using specially trained community health workers ("Community Scientists") to support engagement with an underserved population and to encourage adherence to using wearables and other digital health technologies. In the US, this is especially imperative for the Hispanic/Latino population, which is at high risk for T2D and associated complications.
Key facts
- Study ID
- NCT04820348
- Run by
- Sansum Diabetes Research Institute
- People needed
- 36
- Starts
- 2021-04-09
- Expected to finish
- 2021-08-31
- Last updated by the study team
- 2022-10-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adults ≥ 18 years of age at Visit 1.
- Self-reported Hispanic/Latino heritage.
- Self-reported diagnosis of type 2 diabetes OR self-reported as at risk for developing type 2 diabetes OR healthy individuals who are not at-risk or have diabetes (healthy controls).
- Based on staff's judgment, the subject must have a good understanding, ability, and willingness to adhere to the protocol and to participate in the video-recording part of the study.
- Exclusive and continuous use, for the 2 week participation period, of a study-compatible smartphone.
You may not qualify if…
- Currently taking insulin as treatment for diabetes.
- Pregnant.
- Any active clinically significant disease or disorder, which in the investigator's opinion could interfere with the participation in the trial.
- Mental incapacity, psychiatric disorder, unwillingness or language barriers precluding comprehension of study activities and informed consent.
- Current participation in other trials involving medications or devices.
- Meets criteria for substance use disorders as defined by DSM-5 (e.g., abuse of alcohol, narcotics, or illicit drugs).
- Self-reported diagnosis of bipolar disorder, schizoaffective disorder, schizophrenia or antisocial personality disorder.
- At high risk for suicide based on staff judgement.
- Neuromuscular disease.
Where it is running
- Sansum Diabetes Research Institute — Santa Barbara, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.